We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Lifecore Biomedical
LFCR
$176M
| $1.23M | ﹤0.01% |
+127,067
| New | +$776K |
|
1602
Lindsay Corp
LNN
$1.17B
| $1.23M | ﹤0.01% |
10,267
-7,935
| -44% | -$985K |
|
1603
Applovin
APP
$113B
| $1.22M | ﹤0.01% |
47,492
-133,289
| -74% | -$2.75M |
|
1604
Powell Industries
POWL
$7.55B
| $1.22M | ﹤0.01% |
+60,270
| New | +$1.04M |
|
1605
Matador Resources
MTDR
$6.49B
| $1.21M | ﹤0.01% |
23,156
-263,903
| -92% | -$12.7M |
|
1606
Apogee Enterprises
APOG
$887M
| $1.2M | ﹤0.01% |
+25,300
| New | +$1.06M |
|
|
BRD.WS
1607
CALL
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
| $1.2M | ﹤0.01% |
113,842
-86,158
| -43% | -$4.4K |
|
1608
KT
KT
$8.72B
| $1.19M | ﹤0.01% |
105,722
+38,822
| +58% | +$452K |
|
1609
Helmerich & Payne
HP
$4.18B
| $1.19M | ﹤0.01% |
33,680
-3,320
| -9% | -$113K |
|
1610
BOK Financial
BOKF
$8.7B
| $1.19M | ﹤0.01% |
+14,726
| New | +$1.21M |
|
|
IMAQW
1611
CALL
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
| $1.19M | ﹤0.01% |
110,000
| – | – |
|
1612
Sonos
SONO
$1.83B
| $1.18M | ﹤0.01% |
72,465
-95,837
| -57% | -$1.7M |
|
1613
IHS Holding
IHS
$2.79B
| $1.18M | ﹤0.01% |
+120,989
| New | +$1.06M |
|
1614
CALL
Eli Lilly
LLY
$1.1T
| $1.17M | ﹤0.01% |
+2,500
| New | +$1.05M |
|
1615
Cable One
CABO
$203M
| $1.17M | ﹤0.01% |
+1,784
| New | +$1.2M |
|
1616
Hanover Insurance
THG
$7.86B
| $1.17M | ﹤0.01% |
+10,342
| New | +$1.23M |
|
|
OTLY
1617
Oatly Group
OTLY
$419M
| $1.17M | ﹤0.01% |
28,495
-39,742
| -58% | -$1.62M |
|
1618
Visteon
VC
$2.8B
| $1.17M | ﹤0.01% |
+8,135
| New | +$1.16M |
|
1619
CytomX Therapeutics
CTMX
$750M
| $1.16M | ﹤0.01% |
674,501
-55,437
| -8% | -$92K |
|
1620
Genius Sports
GENI
$2.1B
| $1.16M | ﹤0.01% |
+187,074
| New | +$939K |
|
1621
Devon Energy
DVN
$49.9B
| $1.16M | ﹤0.01% |
+23,949
| New | +$1.2M |
|
|
SNBR
1622
DELISTED
Sleep Number
SNBR
| $1.15M | ﹤0.01% |
42,272
+23,476
| +125% | +$536K |
|
1623
i3 Verticals
IIIV
$328M
| $1.15M | ﹤0.01% |
50,315
-26,892
| -35% | -$627K |
|
1624
Weyerhaeuser
WY
$18.2B
| $1.15M | ﹤0.01% |
+34,289
| New | +$1.03M |
|
1625
CALL
Union Pacific
UNP
$174B
| $1.15M | ﹤0.01% |
+5,600
| New | +$1.11M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.